Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Birmingham secures $44 million in federal Tech Hub grants
Birmingham’s biotech future: How a $44M AI grant could transform the industry
The Birmingham Biotechnology Hub will receive funding to use artificial intelligence to shorten drug development to provide affordable drugs, vaccines and diagnostics.
Birmingham Biotechnology Hub awarded $44 million grant for AI-driven projects
U.S. Rep. Terri Sewell announced that the U.S. Department of Commerce’s Economic Development Administration has awarded a $44 million grant to the Birmingham Bi
$44 million in grants awarded to Birmingham Biotechnology Hub
The Economic Development Administration announced it will award Birmingham Biotechnology Hub $44 million in grants. The hub is led by the Southern Research Institute. The $44 million will implement five projects.
Birmingham Biotech Hub Receives $44M Federal Grant
Federal officials on Tuesday announced that the Birmingham Biotechnology Hub, led by Southern Research, had been awarded a $44 million grant from the U.S. Department of Commerce. “Make no mistake, these dollars are a game changer because they will bring new jobs — thousands of jobs — to the city of Birmingham over the next 10 years in the form of biotechnology jobs,
Birmingham secures $44 million in federal Tech Hub grants for AI and biotech projects
The Magic City is poised to become a national leader in biotechnology. Learn about the five groundbreaking projects that will shape Birmingham's future.
EurekAlert!
3d
Advanced Science: Insilico Medicine utilized AI technology for novel target discovery and drug repurposing to treat endometriosis
Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...
1d
on MSN
AI to shape EU health policymaking without new rules
No specific initiatives on AI in healthcare are in sight but the inevitable impact of this technology will guide EU ...
Harvard Business Review
12d
Why “Living Intelligence” Is the Next Big Thing
AI is merely one facet of a sweeping technological change underway, and companies that fail to recognize the importance of ...
Business Wire
1d
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...
GEN
2d
AI-Designed Antivenom Counteracts Toxins from Snakebites in Mice
The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional ...
devdiscourse
3d
U.S. Implements New Export Controls on Biotech Over Security Concerns
The U.S. Commerce Department is imposing new export controls on biotechnology equipment due to national security concerns ...
4d
on MSN
Here’s Why SoundHound AI, Inc. (SOUN) Is Skyrocketing
We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at ...
17h
on MSN
Ionis Pharmaceuticals EVP sells $213,889 in stock
Following these transactions, Schneider's direct ownership in Ionis Pharmaceuticals (NASDAQ:IONS) stands at 58,508 shares.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback